Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

NCT02548286 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan 8mg
DRUG: Amlodipine 5mg
DRUG: CKD-330 8/5mg

Sponsor

Chong Kun Dang Pharmaceutical